- Home
- COHN vs CLRB Comparison
COHN vs CLRB Comparison
Compare COHN & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COHN
- CLRB
- Stock Information
- Founded
- COHN 1999
- CLRB 2002
- Country
- COHN United States
- CLRB United States
- Employees
- COHN N/A
- CLRB N/A
- Industry
- COHN Investment Bankers/Brokers/Service
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- COHN Finance
- CLRB Health Care
- Exchange
- COHN Nasdaq
- CLRB Nasdaq
- Market Cap
- COHN 21.6M
- CLRB 17.5M
- IPO Year
- COHN N/A
- CLRB N/A
- Fundamental
- Price
- COHN $10.94
- CLRB $4.18
- Analyst Decision
- COHN
- CLRB Hold
- Analyst Count
- COHN 0
- CLRB 2
- Target Price
- COHN N/A
- CLRB N/A
- AVG Volume (30 Days)
- COHN 3.1K
- CLRB 116.2K
- Earning Date
- COHN 11-03-2025
- CLRB 11-17-2025
- Dividend Yield
- COHN 9.43%
- CLRB N/A
- EPS Growth
- COHN 37.63
- CLRB N/A
- EPS
- COHN 1.14
- CLRB N/A
- Revenue
- COHN $133,173,000.00
- CLRB N/A
- Revenue This Year
- COHN N/A
- CLRB N/A
- Revenue Next Year
- COHN N/A
- CLRB N/A
- P/E Ratio
- COHN $9.31
- CLRB N/A
- Revenue Growth
- COHN 78.63
- CLRB N/A
- 52 Week Low
- COHN $6.10
- CLRB $4.11
- 52 Week High
- COHN $13.25
- CLRB $66.00
- Technical
- Relative Strength Index (RSI)
- COHN 50.79
- CLRB 35.43
- Support Level
- COHN $10.55
- CLRB $4.56
- Resistance Level
- COHN $10.94
- CLRB $5.07
- Average True Range (ATR)
- COHN 0.20
- CLRB 0.39
- MACD
- COHN 0.03
- CLRB -0.14
- Stochastic Oscillator
- COHN 67.90
- CLRB 0.00
About COHN Cohen & Company Inc.
Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.